Ozempic costs roughly $935 to $1,475 per month in the United States, depending on the dosage and where you fill it. That’s the price without insurance. With commercial insurance and the manufacturer’s savings card, some patients pay as little as $25 a month, but getting there involves navigating a maze of coverage rules, prior authorizations, and eligibility requirements.
List Price vs. What You Actually Pay
Novo Nordisk sets the wholesale acquisition cost (the official list price before any discounts or rebates) at $968.52 per pen, regardless of whether it’s the 0.5 mg, 1 mg, or 2 mg dose. But the price you see at the pharmacy counter is typically higher. The average retail price across U.S. pharmacies lands around $1,475 for a one-month supply.
Discount programs can cut that significantly. GoodRx coupons bring the price down to about $199 for the lowest-dose pen (2 mg/3 mL, which covers the 0.25 mg and 0.5 mg starter doses), $349 for the mid-range pen, and $499 for the highest-dose pen. These coupon prices don’t require insurance and are available at most major pharmacies, though they fluctuate and vary by location.
What Insurance Typically Covers
Ozempic is FDA-approved for type 2 diabetes, not weight loss. That distinction matters enormously for coverage. If your doctor prescribes it for diabetes, most commercial insurance plans will cover it, though your copay depends on your plan’s formulary tier and deductible structure. If you’re using it off-label for weight management, expect pushback.
Prior authorization requirements have surged in recent years. Among Medicare Part D plans that cover these medications, prior authorization rates jumped from below 25% to over 83% by mid-2024. Commercial insurers have followed a similar pattern. This means your doctor will likely need to submit documentation proving medical necessity before your plan agrees to pay, a process that can take days to weeks.
Medicare currently does not cover Ozempic for weight loss. Starting in July 2026, a new Medicare GLP-1 Bridge program will cover certain weight-loss medications at a $50 copay, but Ozempic is not on the eligible list. That program covers Wegovy, Zepbound, and Foundayo instead. If you’re on Medicare and using Ozempic for diabetes, your Part D plan may still cover it, though copays vary widely depending on the plan.
Novo Nordisk’s Savings Programs
The manufacturer offers two paths to lower prices, depending on your insurance status.
If you have commercial insurance that covers Ozempic, the savings card brings your copay down to as little as $25 per month. The card covers up to $100 in savings per fill and lasts up to 48 months. Government insurance beneficiaries (Medicare, Medicaid, Tricare) are not eligible.
If you’re uninsured or paying out of pocket, Novo Nordisk offers a separate pricing structure. New patients can get their first two monthly fills of the starter doses (0.25 mg and 0.5 mg) for $199 each through an introductory offer available through June 2026. After that, the price is $349 per month for the 0.25 mg, 0.5 mg, or 1 mg doses, and $499 per month for the 2 mg dose. These payments are processed outside of insurance entirely, so they won’t count toward your deductible or out-of-pocket maximum.
For patients with very low incomes, Novo Nordisk runs a Patient Assistance Program that provides medications for free. Eligibility requires U.S. citizenship or legal residency, household income at or below 400% of the federal poverty level, and no private prescription coverage. Some Medicare patients who meet the income threshold may also qualify.
How U.S. Prices Compare Internationally
The gap between what Americans pay and what the rest of the world pays for the same drug is striking. A month’s supply of Ozempic 1 mg costs about $147 in Canada, $169 in Japan, and just $93 in the United Kingdom. According to the Peterson-KFF Health System Tracker, the U.S. list price is over five times what patients pay in Japan and roughly ten times the price in the UK, Sweden, Australia, and France. The medication is identical in every country. The difference is entirely in how each nation negotiates drug prices.
How Ozempic Compares to Similar Drugs
Ozempic isn’t the only GLP-1 medication on the market, and its pricing sits in a similar range to competitors. Wegovy, which is the same active ingredient (semaglutide) but approved specifically for weight loss, carries a comparable list price. Mounjaro and Zepbound, made by Eli Lilly, fall in the same ballpark. For practical purposes, switching between these medications rarely saves money at list price. The real cost difference comes down to which drug your specific insurance plan prefers and places on a lower formulary tier.
The Real Monthly Cost by Situation
- Commercial insurance with savings card: As low as $25 per month
- Commercial insurance without savings card: Varies by plan, commonly $50 to $300+ depending on your tier and deductible
- Uninsured with manufacturer pricing: $199 for starter doses (introductory), then $349 or $499 per month depending on dose
- Uninsured with GoodRx coupon: $199 to $499 per month
- Uninsured at full retail: Approximately $1,475 per month
- Patient Assistance Program (income-eligible): Free
The cost also compounds over time in a way that’s easy to underestimate. At $349 per month, you’re spending over $4,100 a year. At full retail, it’s nearly $17,700 annually. Since Ozempic is designed as a long-term medication (stopping it typically leads to regained weight or worsened blood sugar control), these costs aren’t a short-term commitment. Most patients who benefit from it will need to budget for it indefinitely.